eIF2α Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F0316-20UL

Regular price €149,00 EUR
Regular price Sale price €149,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

EIF2ALPHA is a target of interest in many antibody-based workflows. eIF2 plays a central role in the rate-limiting step of mRNA translation. It binds GTP and Met-tRNAi, facilitating the transfer of Met-tRNAi to the 40S ribosomal subunit. At the end of the initiation process, GTP bound to eIF2 is hydrolyzed to GDP, and phosphorylation of eIF2 alpha effectively inhibits the formation of the eIF2. Depending on the literature source, EIF2ALPHA may also be discussed as EIF2S1.

Reported cellular context includes cytoplasm and mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following EIF2ALPHA across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

EIF2ALPHA is commonly interpreted in the context of infectious disease research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and mitochondrion, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm and mitochondrion across matched conditions
  • host-response changes during infection or pathogen-associated stimulation
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for EIF2ALPHA. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in EIF2ALPHA reflect biology rather than handling. When interpreting EIF2ALPHA, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep EIF2ALPHA trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
EIF2ALPHA
Research Area:
Infectious Disease
Application:
IHC • IP • WB
Reactivity:
Human • Monkey • Mouse • Rat
Specificity:
eIF2α Antibody [C14N24] recognizes endogenous levels of total eIF2α protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
C14N24
UniProt:
P05198
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.